Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Human Health HoldingsHKSE:01419 +0.66%52 PE Ratio (TTM) is 10.48 as of Sep. 05, 2026, which is 15% below its 10-year median of 12.34. GuruFocus rates HKSE:01419 with a GF Score™ of 52/100 and a GF Value™ of HK$0.80 (Fairly Valued). The stock has 3 warning signs investors should review. Among 434 Healthcare Providers & Services companies, Human Health Holdings ranks better than 86.18% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-09-05), Human Health Holdings's share price is
HK$0.765.
Human Health Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.07. Therefore, Human Health Holdings's PE Ratio (TTM) for today is 10.48.
Good Sign:
Human Health Holdings Ltd stock PE Ratio (=10.87) is close to 2-year low of 10.43.
The historical rank and industry rank for Human Health Holdings's PE Ratio (TTM) or its related term are showing as below:
HKSE:01419'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 1.62 Med: 12.34 Max: 78.38
Current: 10.48
During the past 13 years, the highest PE Ratio (TTM) of Human Health Holdings was 78.38. The lowest was 1.62. And the median was 12.34.
HKSE:01419's PE Ratio (TTM) is ranked better than 86.18% of 434
companies
in the Healthcare Providers & Services industry
Industry Median: 21.555
vs HKSE:01419: 10.48
During the past 13 years, Human Health Holdings's highest 3-Year average EPS without NRI Growth Rate was 136.60% per year. The lowest was -59.40% per year. And the median was -19.55% per year.
Human Health Holdings (HKSE:01419) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Human Health Holdings PE Ratio (TTM) Related Terms
Human Health Holdings PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Human Health Holdings's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01419 vs HCA, THC, EHC: PE Ratio (TTM) Comparison
For the Medical Care Facilities subindustry, Human Health Holdings's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Health Holdings PE Ratio (TTM) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Human Health Holdings's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Human Health Holdings's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Human Health Holdings's Share Price of today is HK$0.765.
For company reported semi-annually, Human Health Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Human Health Holdings (HKSE:01419) has a PE Ratio (TTM) of 10.48 as of Sep. 05, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Human Health Holdings and its competitors. This is 15% below median its historical median of 12.34. Over the past decade, Human Health Holdings' PE Ratio (TTM) has ranged from 1.62 to 78.38. According to the industry distribution chart, Human Health Holdings ranks #60 out of 434 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Human Health Holdings' PE Ratio (TTM) too high?
Human Health Holdings' current PE Ratio (TTM) of 10.48 is 15% below median its 10-year median of 12.34. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 78.38. The Healthcare Providers & Services industry median PE Ratio (TTM) is 21.56. Human Health Holdings' value of 10.48 is 51.4% below this industry median. Based on the distribution chart, Human Health Holdings ranks #60 out of 434 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Human Health Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Human Health Holdings' PE Ratio (TTM) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Human Health Holdings ranks #60 out of 434 companies for PE Ratio (TTM). This places Human Health Holdings in the top 14% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 21.56. Human Health Holdings' value of 10.48 is 51.4% below this benchmark. Historically, Human Health Holdings' own PE Ratio (TTM) has ranged from 1.62 to 78.38 over the past decade. While the company's 10-year median is 12.34 vs. the industry median of 21.56, Human Health Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 21.56, based on 434 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Health Holdings's current PE Ratio (TTM) of 10.48 is 51.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Human Health Holdings and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 21.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Health Holdings's current PE Ratio (TTM) is 10.48, which is 15% below median its own 10-year median of 12.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Human Health Holdings (HKSE:01419) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.80, compared to a current price of HK$0.77 — trading 4.4% below its estimated fair value. The current PE Ratio (TTM) is 10.48, which is 15% below median its 10-year median of 12.34 and 51.4% below the Healthcare Providers & Services industry median of 21.56. Human Health Holdings' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Human Health Holdings (HKSE:01419), the current PE Ratio (TTM) is 10.48 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Human Health Holdings (HKSE:01419) Overvalued in 2026?
Based on GuruFocus' analysis, Human Health Holdings stock appears to be undervalued.
The current stock price of HK$0.77 is trading 4.4% below its estimated GF Value™ of HK$0.80.
GuruFocus considers Human Health Holdings to be Fairly Valued.
Key valuation signals for HKSE:01419:
PE Ratio (TTM): 10.48 (15% below median its 10-year median of 12.34)
GF Value™: HK$0.80 vs. price of HK$0.77 (4.4% below fair value)
Industry Position: 51.4% below the Healthcare Providers & Services median (#60 of 434)
No single metric tells the full story. See the HKSE:01419 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Human Health Holdings Ltd is engaged in the provision of healthcare services. The company segments include general practice services, specialties services, and dental services. It offers general practice services, including general consultation, diagnostics, and preventative health, minor procedure, vaccination, physical check-up, health education, occupational health advisory, Cardiology, Dental Implant, Urology, work injury assessment services, Orthodontics and others. It generates maximum revenue from the general practice services segment.
52GF Score
Get the complete analysis for HKSE:01419
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01419 has been successfully added to your 
